Isoxsuprine PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Isoxsuprine PCD pharma franchise company offering 4 tablet formulations. Manufactured under WHO-GMP certified standards, this range gives franchise partners a dependable obstetric and peripheral-vascular molecule with steady gynaecology demand.
What is Isoxsuprine?
Isoxsuprine is a beta-adrenergic agonist and peripheral vasodilator. By stimulating beta-2 receptors it relaxes vascular and uterine smooth muscle, increasing blood flow and reducing uterine contractility. These actions underlie its two main roles: as a uterine relaxant (tocolytic) and as a vasodilator in circulatory disorders. Learn more on PubChem.
Therapeutic Applications of Isoxsuprine
Isoxsuprine is used to manage threatened or premature labour by relaxing the uterus, and to improve circulation in peripheral vascular diseases and cerebrovascular insufficiency. It is prescribed mainly by gynaecologists and obstetricians, and by physicians treating vascular conditions.
Why Isoxsuprine is a High-Potential Molecule for Distributors
Obstetric care is a consistently high-volume prescription segment in India, and isoxsuprine remains a familiar, economical uterine relaxant widely used in maternity practice. Its dual obstetric-and-vascular utility and low price sensitivity give distributors a steady, dependable molecule that pairs well with a broader gynaecology and general range.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.
References
- PubChem – Isoxsuprine Compound Summary, U.S. National Library of Medicine
- PubMed – Clinical literature on Isoxsuprine
Our formulations of Isoxsuprine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: